Form D · Other Health Care
Alpfa Medical, Inc.
Palo Alto, CA · CIK 0002156252
Offering snapshot reported Sep 28, 2026 · SEC filing
- Reported sold
- $80.3M Offering amount: $100M
- Investors reported
- 71 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 11, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 28, 2026 | Initial | $80,268,077 | No comparison | 71 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598962
Series B-1 + Series B-2 Preferred Stock and the Common Stock issuable upon conversion thereof. Includes $30,268,087in value of cancelled convertible instruments. The remaining $19,999,978 of the total offering amount reserved for future milestone closings
Offering of preferred stock and the underlying common stock issuable upon conversion of the preferred stock.
Source: Form D, filed Sep 28, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Bonita | Director |
| Andrew El Bardissi | Director |
| Michael Hurley | Director |
| Michael Kramer | Director |
| Rupa Patel | Executive |
| Raju Viswanathan | Director |
| Michael Wiley | Director, Executive |
| Allan Zingeler | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1880 Embarcadero Road
Palo Alto, CA, 94303
Palo Alto, CA, 94303